Skip Navigation Links
SEARCH  



 
Bookmark and Share
Bionomics BNC210 Expansion into Social Anxiety Disorder
Rapid oral absorption of BNC210 novel tablet formulation ideally suited for acute treatment of anxiety in patients with Social Anxiety Disorder BNC210 Phase 2b PTSD trial on target for start in mid-2021 with U.S....

Full "IntellAsia: Resources" article




Disclaimer | Terms Of Use And Privacy Statement


© Metals News. All rights reserved.